Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literature

Few reports have described the coincidence of chronic lymphocytic leukemia (CLL) and HIV. We administered bendamustine to an HIV‐positive refractory CLL patient and obtained a significant objective response. Our results indicate that bendamustine can be used in HIV‐infected CLL patients. We also reviewed 12 cases of CLL with HIV infection.

• Publication year

  2015

• Venue

  Clinical Case Reports

• Publication date

  2015-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccr3.244PMID 26185648PMCID 4498862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bendamustine for treatment of chronic lymphocytic leukemia

  2012cited by this paper
• Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.

  2012cited by this paper
• Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment

  2011cited by this paper
• Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel.

  2010cited by this paper
• An Overview of the Mechanisms of HIV-Related Thrombocytopenia

  2010cited by this paper
• Characterization of Lymphomas in a High Prevalence HIV Setting

  2010cited by this paper
• Lopinavir/Ritonavir

  2010cited by this paper
• A systematic review on Richter syndrome: what is the published evidence?

  2010cited by this paper
• Human immunodeficiency virus and chronic lymphocytic leukemia

  2009influential reference
• AIDS-related lymphomas in Nigeria.

  2009cited by this paper
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

  2008cited by this paper
• Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

  2008cited by this paper
• Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride

  2007cited by this paper
• Management of infectious complications in patients with chronic lymphocytic leukemia.

  2007cited by this paper
• Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

  2006cited by this paper
• Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.

  2005cited by this paper
• HIV-1 infection in adults with haematological malignancies in Yaoundé, Cameroon.

  2004cited by this paper
• Cancer Facts & Figures 2004

  2004cited by this paper
• Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications.

  2003influential reference
• Results of First Salvage Therapy for Patients Refractory to a Fludarabine Regimen in Chronic Lymphocytic Leukemia

  2002cited by this paper
• In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia

  2002cited by this paper
• Characteristics of indolent non‐hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection

  2002cited by this paper
• Association of cancer with AIDS-related immunosuppression in adults.

  2001cited by this paper
• Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia

  2001cited by this paper
• Characterization of T Lymphocyte Subset Alterations by Flow Cytometry in HIV Disease

  1993cited by this paper
• Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).

  1988cited by this paper
• Chronic lymphocytic leukaemia contemporaneous with HIV infection.

  1987cited by this paper
• Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors.

  1987cited by this paper
• Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease.

  1986cited by this paper

• A computational framework to explore cellular response mechanisms from multi-omics datasets

  2020cites this paper
• Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib

  2018cites this paper
• HIV and Indolent Lymphoma

  2016cites this paper